Translocation t(1;3)(p36;q21) in malignant myeloid stem cell disorders
- 1 May 1986
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 22 (1) , 75-81
- https://doi.org/10.1016/0165-4608(86)90140-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Translocation (1;7)(p11;p11): A new myeloproliferative hematologic entityCancer Genetics and Cytogenetics, 1985
- Combined trisomy 1q and monosomy 7q due to translocation 1;7 in myelodysplastic syndromesCancer Genetics and Cytogenetics, 1985
- Translocation 1;7 in preleukemic statesCancer Genetics and Cytogenetics, 1985
- The 5q− anomalyCancer Genetics and Cytogenetics, 1985
- Translocation (1,3) in myelodysplastic disorders [letter]Blood, 1985
- Clinical correlations of the 3q21;q26 cytogenetic anomaly. A leukemic or myelodysplastic syndrome with preserved or increased platelet production and lack of response to cytotoxic drug therapyCancer, 1985
- A new translocation, t(1;3) (p36;q21), in myelodysplastic disordersBlood, 1984
- Association of an Inversion of Chromosome 16 with Abnormal Marrow Eosinophils in Acute Myelomonocytic LeukemiaNew England Journal of Medicine, 1983
- Chromosome 3 abnormalities in acute nonlymphocytic leukemia (ANLL) with abnormal thrombopoiesis: report of three patients with a "new" inversion anomaly and a further case of homologous translocationBlood, 1982
- Therapy-related leukemia. A panmyelosisCancer, 1979